From: FGFR1 and WT1 are markers of human prostate cancer progression
Characteristics | All patients (n = 85) |
---|---|
Median age (years) | 62 |
TNM classification: | |
pT0 | 11 |
pT1 | 0 |
pT2a | 10 |
pT2b | 30 |
pT3a | 28 |
pT3b | 17 |
T3N1M1b | 3 |
T3N1M1c | 2 |
Gleason grading: | |
5 | 4 |
6 | 8 |
7 | 53 |
8 | 15 |
9 | 5 |
Median follow-up (months) | 60 |
Metastatic relapse (n) | 4 |
Death (n) | 3 |